Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion, |
RCV002251088 | SCV002521486 | likely pathogenic | Charlevoix-Saguenay spastic ataxia | 2022-05-22 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift: predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. Multiple pathogenic variants are reported in the predicted truncated region. Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. |